Table 2.

Staging of 140 patients with lymphoma: results of DWI-MRI in Group A (DLBCL, follicular lymphoma, Hodgkin lymphoma, nMZL, MCL, peripheral T-cell lymphoma, and ALCL), and DWI-MRI, 18F-FDG-PET/CTa, CE-CT, and the combination of 18F-FDG-PET/CT and CE-CTb in Group B (MALT lymphoma, SLL/CLL)

Reference standard
Stage 0Stage IStage IIStage IIIStage IVTotal
Group A
 Stage 0DWI-MRI10200012
 Stage IDWI-MRI02511027
 Stage IIDWI-MRI01150016
 Stage IIIDWI-MRI00019019
 Stage IVDWI-MRI00012526
 Total1028162125100
Group B
 Stage 0DWI-MRI9200011
PET/CTa9900220
CE-CT4800113
CE-CT+PET/CTb450009
 Stage IDWI-MRI01600016
PET/CTa0811010
CE-CT51000217
CE-CT+PET/CTb61110018
 Stage IIDWI-MRI001001
PET/CTa011002
CE-CT002002
CE-CT+PET/CTb002002
 Stage IIIDWI-MRI000202
PET/CTa000101
CE-CT000202
CE-CT+PET/CTb000202
 Stage IVDWI-MRI0010910
PET/CTa000077
CE-CT000066
CE-CT+PET/CTb110079
Total91822940
  • aCT used only for anatomic and morphologic correlation.

  • bIn case of a disagreement between PET/CT and CE-CT, the higher stage was used.